Compared to the manual process the CytoCare robot reduces the spread of drugs and thereby the risk of operator exposure by a factor of a million.
Vagn Handlos,
Senior Scientist, assign. Prof., Dr. Sci. (Pharm), PH.D. Capital Region Pharmacy, Copenhagen, Denmark
Vagn Handlos,
Senior Scientist, assign. Prof., Dr. Sci. (Pharm), PH.D. Capital Region Pharmacy, Copenhagen, Denmark
CytoCare
![]() | In the critical area of cancer care, healthcare providers are experiencing growing pressure to improve patients safety and decrease operator’s risk while at the same time working more efficiently and containing costs. The higher incidence rate of cancer and the growing complexity of treatment protocols, combined with a shortage of qualified staff, results in an increasing workload which directly affects the quality of patient services. Some of the most serious issues with cancer care include: + Patient Safety + Operational Safety + Suboptimal Allocation of Resources CytoCare directly addresses these challenges, as it the complex and dangerous tasks associated with CSP (Compounded Sterile Preparations), increasing quality and overall competitiveness. |
Downloads
News




